Semler Scientific Inc
SMLR
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
5.9% downsideOvervalued by 5.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $310.75 Million |
|---|---|
| Enterprise Value | $418.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.66 |
| Beta | 1.32 |
| Outstanding Shares | 14,848,408 |
Return
| Return on Equity | 10.51% |
|---|---|
| Return on Assets | 8.10% |
| Return on Invested Capital | -6.15% |
Valuation & Multiples
| P/E Ratio | 6.24 |
|---|---|
| PEG | 3.1 |
| Price to Sales | 10.17 |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | 11.31 |
| Enterprise Value to EBIT | -11.95 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6771▲ 3.60% |
|---|---|
| Total Calls | 532,400▼ 35.24% |
| Total Puts | 360,500▼ 31.61% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 72.07%▲ 5.43% |
|---|---|
| Total Invested | $163.63M▼ 44.86% |
| Investors Holding | 113▼ 32.00% |
ESG Score
No data
About Semler Scientific Inc
86 employees
CEO: Douglas Murphy-Chutorian Relevant Senate Committees
This committee oversees Medicare and Medicaid reimbursement policy; SMLR's revenue is highly sensitive to the specific insurance codes and reimbursement rates for vascular testing.
This committee oversees the FDA, which regulates Semler's medical devices, and handles general healthcare policy that dictates industry standards.
Due to Semler Scientific’s specific corporate strategy of holding Bitcoin as a primary treasury reserve asset, this committee’s regulation of digital assets and SEC oversight is highly relevant.